Literature DB >> 11186307

Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment.

D Wodarz1, M A Nowak.   

Abstract

A very important question in immunology is to determine which factors decide whether an immune response can efficiently clear or control a viral infection, and under what circumstances we observe persistent viral replication and pathology. This paper summarizes how mathematical models help us gain new insights into these questions, and explores the relationship between antiviral therapy and long-term immunological control in human immunodeficiency virus (HIV) infection. We find that cytotoxic T lymphocyte (CTL) memory, defined as antigen-independent persistence of CTL precursors, is necessary for the CTL response to clear an infection. The presence of such a memory response is associated with the coexistence of many CTL clones directed against multiple epitopes. If CTL memory is inefficient, then persistent replication can be established. This outcome is associated with a narrow CTL response directed against only one or a few viral epitopes. If the virus replicates persistently, occurrence of pathology depends on the level of virus load at equilibrium, and this can be determined by the overall efficacy of the CTL response. Mathematical models suggest that controlled replication is reflected by a positive correlation between CTLs and virus load. On the other hand, uncontrolled viral replication results in higher loads and the absence of a correlation between CTLs and virus load. A negative correlation between CTLs and virus load indicates that the virus actively impairs immunity, as observed with HIV. Mathematical models and experimental data suggest that HIV persistence and pathology are caused by the absence of sufficient CTL memory. We show how mathematical models can help us devise therapy regimens that can restore CTL memory in HIV patients and result in long-term immunological control of the virus in the absence of life-long treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11186307      PMCID: PMC1692817          DOI: 10.1098/rstb.2000.0643

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  39 in total

1.  HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.

Authors:  B A Larder; G Darby; D D Richman
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

Review 2.  Immune protection vs. immunopathology vs. autoimmunity: a question of balance and of knowledge.

Authors:  R M Zinkernagel
Journal:  Brain Pathol       Date:  1993-04       Impact factor: 6.508

3.  Population dynamics of immune responses to persistent viruses.

Authors:  M A Nowak; C R Bangham
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

4.  HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.

Authors:  A S Perelson; A U Neumann; M Markowitz; J M Leonard; D D Ho
Journal:  Science       Date:  1996-03-15       Impact factor: 47.728

5.  High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis.

Authors:  S Daenke; A G Kermode; S E Hall; G Taylor; J Weber; S Nightingale; C R Bangham
Journal:  Virology       Date:  1996-03-01       Impact factor: 3.616

Review 6.  Immunology taught by viruses.

Authors:  R M Zinkernagel
Journal:  Science       Date:  1996-01-12       Impact factor: 47.728

7.  Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.

Authors:  T Harrer; E Harrer; S A Kalams; P Barbosa; A Trocha; R P Johnson; T Elbeik; M B Feinberg; S P Buchbinder; B D Walker
Journal:  J Immunol       Date:  1996-04-01       Impact factor: 5.422

8.  In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors.

Authors:  J H Condra; W A Schleif; O M Blahy; L J Gabryelski; D J Graham; J C Quintero; A Rhodes; H L Robbins; E Roth; M Shivaprakash
Journal:  Nature       Date:  1995-04-06       Impact factor: 49.962

9.  Antigenic oscillations and shifting immunodominance in HIV-1 infections.

Authors:  M A Nowak; R M May; R E Phillips; S Rowland-Jones; D G Lalloo; S McAdam; P Klenerman; B Köppe; K Sigmund; C R Bangham
Journal:  Nature       Date:  1995-06-15       Impact factor: 49.962

10.  CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.

Authors:  P Borrow; A Tishon; S Lee; J Xu; I S Grewal; M B Oldstone; R A Flavell
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  4 in total

1.  Dynamics of recurrent viral infection.

Authors:  W Yao; L Hertel; L M Wahl
Journal:  Proc Biol Sci       Date:  2006-09-07       Impact factor: 5.349

2.  Virus replication strategies and the critical CTL numbers required for the control of infection.

Authors:  Andrew J Yates; Minus Van Baalen; Rustom Antia
Journal:  PLoS Comput Biol       Date:  2011-11-17       Impact factor: 4.475

Review 3.  Gaining insights into human viral diseases through mathematics.

Authors:  Seyed M Moghadas
Journal:  Eur J Epidemiol       Date:  2006-05-23       Impact factor: 8.082

4.  A model of HIV drug resistance driven by heterogeneities in host immunity and adherence patterns.

Authors:  Anna Bershteyn; Philip A Eckhoff
Journal:  BMC Syst Biol       Date:  2013-02-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.